Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies

M Wassef, F Blei, D Adams, A Alomari, E Baselga… - …, 2015 - publications.aap.org
Vascular anomalies represent a spectrum of disorders from a simple “birthmark” to life-
threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced …

[HTML][HTML] Venous malformations: clinical diagnosis and treatment

S Behravesh, W Yakes, N Gupta, S Naidu… - Cardiovascular …, 2016 - ncbi.nlm.nih.gov
Venous malformation (VM) is the most common type of congenital vascular malformation
(CVM). They are present at birth and are often symptomatic, causing morbidity and pain …

[HTML][HTML] Vascular anomalies (part I): classification and diagnostics of vascular anomalies

M Sadick, R Müller-Wille, M Wildgruber… - RöFo-Fortschritte auf …, 2018 - thieme-connect.com
Background Vascular anomalies are a diagnostic and therapeutic challenge. They require
dedicated interdisciplinary management. Optimal patient care relies on integral medical …

Parkes Weber syndrome—Diagnostic and management paradigms: A systematic review

I Banzic, M Brankovic, Ž Maksimović… - …, 2017 - journals.sagepub.com
Objectives Parkes Weber syndrome is a congenital vascular malformation which consists of
capillary malformation, venous malformation, lymphatic malformation, and arteriovenous …

Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial

P Zamboni, L Tesio, S Galimberti, L Massacesi… - JAMA …, 2018 - jamanetwork.com
Importance Chronic cerebrospinal venous insufficiency (CCSVI) is characterized by
restricted venous outflow from the brain and spinal cord. Whether this condition is …

Mosaic abnormalities of the skin: review and guidelines from the European Reference Network for rare skin diseases

VA Kinsler, O Boccara, S Fraitag… - British Journal of …, 2020 - academic.oup.com
Background Cutaneous mosaicism is an area of dermatology in which there has been an
explosion of knowledge within the current decade. This has led to fundamental changes in …

Off-label use of sirolimus and everolimus in a pediatric center: a case series and review of the literature

M Bevacqua, F Baldo, S Pastore, E Valencic… - Pediatric Drugs, 2019 - Springer
Background It has been 15 years since sirolimus, an mTOR inhibitor, received Food and
Drug Administration approval to prevent acute rejection in kidney transplantation, and 8 …

[HTML][HTML] Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia

P Chowdary - International journal of hematology, 2020 - Springer
Novel approaches to the treatment of haemophilia are needed due to the limitations of the
current standard of care, factor replacement therapy. Aspirations include lessening the …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases

CP Twine, SK Kakkos, V Aboyans… - European Journal of …, 2023 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children

JN Markovic, U Nag, CK Shortell - Journal of Vascular Surgery: Venous and …, 2020 - Elsevier
Objective Congenital vascular malformations are a heterogeneous group of lesions with the
potential to cause significant lifelong morbidity in children. Diagnosis and treatment of these …